公开(公告)号：WO2011117404A3

公开(公告)日：2011-09-29

申请号：PCT/EP2011/054649

申请日：2011-03-25

Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH ,  WIMPENNY, Steven ,  O'HARE, Aidan Michael ,  YATES, Barry ,  DAY, Shane Alistair

Inventor： WIMPENNY, Steven ,  O'HARE, Aidan Michael ,  YATES, Barry ,  DAY, Shane Alistair

IPC: A61M5/00

Abstract: An electro-mechanical drug delivery device (800, 821, 850, 952) comprises a main body (802, 822, 852, 902, 956) having a distal end (808, 828, 910) and a proximal end (806, 826, 958). The distal end (808, 828, 910) is configured to attach to a dispense interface. A separable housing (804, 824, 854, 904, 962) that can prevent an administration of a drug by the drug delivery device (800, 821, 850, 952), the housing configured to cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) when the separable housing (804, 824, 854, 904, 962) is coupled to the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952). A conduction element (856, 906) is provided by the main body (802, 822, 852, 902, 956) and configured for establishing an electrical connection with an electrical connector (849, 862, 968). Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956). The electrical connection may be established when the housing covers at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952).

公开(公告)号：WO2011117404A2

公开(公告)日：2011-09-29

申请号：PCT/EP2011054649

申请日：2011-03-25

Applicant: SANOFI AVENTIS DEUTSCHLAND ,  WIMPENNY STEVEN ,  O'HARE AIDAN MICHAEL ,  YATES BARRY ,  DAY SHANE ALISTAIR

Inventor： WIMPENNY STEVEN ,  O'HARE AIDAN MICHAEL ,  YATES BARRY ,  DAY SHANE ALISTAIR

IPC: A61M5/00

CPC classification number: A61M5/20 ,  A61M5/002 ,  A61M5/19 ,  A61M5/24 ,  A61M5/2448 ,  A61M5/3146 ,  A61M5/31546 ,  A61M5/345 ,  A61M2005/2496 ,  A61M2005/3104 ,  A61M2005/3125 ,  A61M2005/3126 ,  A61M2005/3128 ,  A61M2005/31588 ,  A61M2039/1083 ,  A61M2039/1088 ,  A61M2205/3584 ,  A61M2205/50 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2205/6072 ,  A61M2205/8206 ,  A61M2205/8212 ,  A61M2205/8256 ,  A61M2209/086 ,  H02J7/0047

Abstract: An electro-mechanical drug delivery device (800, 821, 850, 952) comprises a main body (802, 822, 852, 902, 956) having a distal end (808, 828, 910) and a proximal end (806, 826, 958). The distal end (808, 828, 910) is configured to attach to a dispense interface. A separable housing (804, 824, 854, 904, 962) that can prevent an administration of a drug by the drug delivery device (800, 821, 850, 952), the housing configured to cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) when the separable housing (804, 824, 854, 904, 962) is coupled to the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952). A conduction element (856, 906) is provided by the main body (802, 822, 852, 902, 956) and configured for establishing an electrical connection with an electrical connector (849, 862, 968). Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956). The electrical connection may be established when the housing covers at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952).

Abstract translation: 一种机电药物输送装置（800,821,850,952）包括具有远端（808,828,910）和近端（806,826）的主体（802,822,852,902,956） ，958）。 远端（808,828,910）构造成附接到分配接口。 一种可分开的壳体（804,824,854,904,962），其可以防止由药物输送装置（800,821,850,952）施用药物，所述壳体被构造成覆盖远端的至少一部分 （804,824,854,904,962）与所述主体（802,822,852,902,905）相连接时，所述主体（802,822,852,902,905）在所述主体（802,822,852,902,956） （800,821,850,952）的至少一部分（例如，902,956）。 导电元件（856,906）由主体（802,822,852,902,956）提供并且被配置用于建立与电连接器（849,862,968）的电连接。 当壳体未覆盖主体（802,822,852,902,956）的远端（808,828,910）的至少一部分时，防止电连接的建立。 当壳体覆盖药物输送装置（800,821,820）的主体（802,822,852,902,956）的远端（808,828,910）的至少一部分时，可建立电连接。 850，952）。

公开(公告)号：WO2008090318A1

公开(公告)日：2008-07-31

申请号：PCT/GB2008/000197

申请日：2008-01-21

Applicant: CONSORT MEDICAL PLC ,  WARBY, Richard, John ,  ALLSOP, Paul ,  DICKENS, Colin ,  GLENTON, David, Jonathan ,  BAINTON, Michael, Cameron ,  DAY, Shane, Alistair ,  PERKINS, Robert ,  KELLY, Stuart, George, David

Inventor： WARBY, Richard, John ,  ALLSOP, Paul ,  DICKENS, Colin ,  GLENTON, David, Jonathan ,  BAINTON, Michael, Cameron ,  DAY, Shane, Alistair ,  PERKINS, Robert ,  KELLY, Stuart, George, David

IPC: F16K11/074

CPC classification number: F16K11/074 ,  B05B3/025 ,  B05B3/026 ,  B05B12/06 ,  B65D83/262 ,  B65D83/54

Abstract: A metering valve for a pressurised dispensing container comprising a metering chamber (5); an inlet (9) to the metering chamber; an outlet (10) to the metering chamber; one or more inlet sealing members (7) for sealing the inlet (9) to the metering chamber (5), and one or more outlet sealing members (8) for sealing the outlet (10) to themetering chamber (5). The metering chamber (5) is static and the one or more inlet sealing members (7) are rotatable between a first position, in which the inlet (9) to the metering chamber is open, and a second position, in which the inlet (9) to the metering chamber is closed, and the one or more outlet sealing members (8) are rotatable between a first position, in which the outlet (10) to the metering chamber is closed, and a second position, in which the outlet (10) to the metering chamber is open.

Abstract translation: 一种用于加压分配容器的计量阀，包括计量腔（5）; 入口（9）到计量室; 出口（10）到计量室; 用于将入口（9）密封到计量室（5）的一个或多个入口密封构件（7）以及用于将出口（10）密封到定量室（5）的一个或多个出口密封构件（8）。 计量室（5）是静态的，并且一个或多个入口密封构件（7）可在第一位置（其中计量室的入口（9）打开）和第二位置之间旋转，在第二位置，入口 关闭计量室，并且一个或多个出口密封构件（8）可在其中关闭计量室的出口（10）的第一位置和第二位置之间旋转，在第二位置，出口 （10）到计量室是打开的。

公开(公告)号：WO2003051429A1

公开(公告)日：2003-06-26

申请号：PCT/GB2002/005695

申请日：2002-12-16

Applicant: DCA DESIGN INTERNATIONAL LIMITED ,  LANGLEY, Christopher, Nigel ,  VEASEY, Robert, Frederick ,  WOOLSTON, Robert ,  DAY, Shane, Alistair

Inventor： LANGLEY, Christopher, Nigel ,  VEASEY, Robert, Frederick ,  WOOLSTON, Robert ,  DAY, Shane, Alistair

IPC: A61M5/145

CPC classification number: A61M5/24 ,  A61M5/14566 ,  A61M5/16831 ,  A61M5/31525 ,  A61M5/31546 ,  A61M5/3157 ,  A61M5/31591 ,  A61M2005/31588 ,  A61M2205/52 ,  A61M2205/581

Abstract: The present invention relates to a medicament injection apparatus, particularly suitable for use by those with diabetes in which, in use, once a desired dosage of medicament has been selected and expelled from the medicament cartridge into the body of the patient, the injected medicament is allowed to disperse locally from the injection site within the patient's body before the needle arrangement is removed from the patient's body. It is considered to be a problem that in known medicament injection devices the injection interval, that is the time elapsed since a previous injection, is measured following completion of a delivery stroke rather than from dispersion of the injected medicament. A medicament injection device is disclosed in which the time elapsed following an injection operation is calculated from the end of a predetermined period during which medicament is permitted to disperse subsequent to completion of an injection stroke.

Abstract translation: 本发明涉及特别适合于糖尿病患者使用的药物注射装置，其中在使用中，一旦选择了所需剂量的药物并将其从药剂盒中排出到患者体内，注射的药物是 在将针装置从患者身体移除之前，允许在患者体内的注射部位局部分散。 认为在已知的药物注射装置中，注射间隔（即先前注射后经过的时间）是在完成输送冲程而不是从注射药物的分散之后测量的问题。 公开了一种药剂注射装置，其中从注射操作完成之后允许药物分散的预定时间段结束时计算注射操作之后的时间。